Undercover at a black market ‘skinny jab party'
ITV News Health Correspondent Rebecca Barry and Senior Producer Liz Little investigate the 'lethal' skinny jab black market
ITV News has filmed undercover at a 'skinny jab party' where unlicensed weight-loss injections were illegally sold.
Undercover journalists were able to buy pre-filled syringes of semaglutide, some of which contained ten times the recommended dosage.
One doctor described it as 'unethical' with potentially 'lethal' consequences.
The undercover filming was part of a months-long investigation by ITV News and the Tonight programme into the skinny jab black market, which also found videos on social media of an NHS employee illegally promoting weight-loss jabs.
ITV News bought skinny jab pens via an Instagram account, which had posted some of the videos, and tests later revealed the substance was unfit for human use.
Weight-loss medications can only be legally and safely dispensed with a prescription from a healthcare professional.
It is against the law to advertise prescription-only medications.
But with more people than ever living with obesity, long NHS waiting lists for weight-loss drugs and high private costs, many are turning to risky alternatives.
Social media is flooded with content promoting and selling unlicensed and potentially dangerous products.
Among the thousands of illegal adverts, ITV News found a Facebook post offering a 'skinny jab party'.
It read: 'If you host a skinny jab party at your home for five guests... The host gets to pick £120 worth of treatments for free. Inbox me for details.'
Our undercover journalists, posing as a group of women on a hen do, arranged to meet the woman.
In secretly recorded footage, she asked the group how much weight they wanted to lose before the wedding, without checking their age, BMI or medical history.
She confirmed she was not a healthcare professional and claimed to be selling Mounjaro - the brand name for the weight-loss drug tirzepatide.
She was recorded saying that she buys it 'in bulk' from a pharmacy in powder form and mixes it herself, so she can supply it 'cheaper'.
The 'skinny jab party' included a demonstration of how to use the drug, in which the woman injected herself in the stomach with a needle she had stored in a Tupperware container.
When asked about the potential risks, she told the group that they could 'get sick' and have diarrhoea.
She said she'd had two customers who had 'been very sick", but it was 'always the really skinny girls".
She told them people had died, but they weren't her clients.
They paid £120 each for a six-week supply – except for the 'bride', who got hers free.
The woman gave each of the undercover journalists a colourful envelope tied with a ribbon, containing the pre-filled syringes.
ITV News had the syringes tested in a laboratory and found they did not contain any tirzepatide, as the seller had claimed.
Tests revealed they contained another prescription-only weight-loss drug, semaglutide.
Some of the syringes had ten times the recommended dosage.
If you've got a story you'd like to share with ITV News, email investigations@itv.com.
You can watch Tonight - 'Undercover: Skinny Jabs Exposed' on ITV1 and ITVX on Thursday 15 May at 8.30pm.
ITV News showed the undercover footage to Dr Semiya Aziz, a GP who regularly prescribes weight-loss drugs.
Dr Aziz said she was 'angry' watching the medication being distributed at a party, describing it as 'illegal and unethical".
She said the 'unsterile' syringes were 'scary' and that 'someone could end up in hospital' after using them, which could be 'lethal".
The woman who provided the skinny jab party told us that she had been 'scammed' by the pharmacy which supplied the drugs.
She said she always explains the positives and negatives of the product she sells and gets many recommendations from her clients who are happy with her work.
She said she only wanted to help people and that she would learn from this experience.
ITV News tracked a number of other online sellers exploiting those who are desperate to lose weight.
We found videos of a woman in an NHS uniform, recorded in what looks like a clinical setting, illegally promoting unlicensed weight loss drugs.
Our investigation confirmed that the woman is called Victoria and she worked for an NHS Trust in North West England until December 2024.
In one video posted to Instagram, she said: 'I've worked in the medical industry now for 23 years.'
Some videos offered 'vials' of weight-loss medications for a 'fraction of the price' or 'two for one' deals on disposable pens.
ITV News contacted an Instagram account, which had posted some of the videos, asking how to buy the jabs.
We were directed to a WhatsApp account and were sent a product price list and payment details.
After transferring £170, two 'Raw Pharma Semaglutide' pens were sent in the post.
ITV News understands the WhatsApp account and 'Raw Pharma' are linked to British man Dale Dennis, who is currently living in Thailand.
While Dale uses the name 'Raw Pharma', there's no suggestion he's linked to other businesses with the same name.
Dale appears in dozens of social media videos offering sales of unlicensed drugs.
He also presented a podcast, in which he introduces a video of Victoria, describing her as a Raw Pharma 'partner' and 'nurse'.
ITV News has confirmed Victoria was not a nurse, but she did work for the NHS.
The 'Raw Pharma Semaglutide' pens we received were tested in a laboratory.
Scientists found they contained no trace of semaglutide, were contaminated with bacteria and 'not fit for human use".
Dr Stephen Childs, Senior Lecturer in Pharmaceutical Chemistry at the University of Sunderland, described the pens as some of the 'most concerning' he had seen.
Dr Childs said the 'considerable contamination' could cause an allergic reaction or serious infection.
'Someone's bought this under the impression it's been tested and that it's a safe product. That's clearly not a process these types of products go through - unlike genuine pharmaceuticals.'
ITV News tried to contact Dale Dennis. He didn't respond to any of the allegations put to him.
He said that he has a 'company that sells consultations' and that he is 'not affiliated' to Victoria.
Dale said he would be interested in an interview, but when ITV News tried to arrange it, he didn't reply.
Victoria did respond, saying she 'does not have a commercial relationship with Dale Dennis or his companies'.
She told ITV News that Dale asked her to do a 'review' of the products, which she did on a 'few occasions'.
But she said she did not know the videos would be 'edited' to be used as 'a sales pitch' and that 'under no circumstances' was she informed it 'would be used for advertising'.
She said she has 'never facilitated' the sale of weight loss drugs.
In response to our investigation, the medicines regulator said staff are working 'round the clock' to tackle the skinny jabs black market.
Head of the MHRA's Criminal Enforcement Unit, Andy Morling, told the Tonight programme they 'are taking it very seriously".
'We are stopping it happening. We have a number of investigations ongoing at the moment. We're tackling the supply of these products by taking out the criminals that sit behind them," he said.
'We work very closely with social media companies to try and remove illegally trading websites and we've removed several hundred illegal postings on Facebook and other social media outlets over the last two years.'
A Department of Health and Social care spokesperson told ITV News: 'This is completely unacceptable. These are unlicensed medicines with potentially serious side effects and should under no circumstances be used for cosmetic purposes .
'There can be real health benefits if these treatments are provided safely to the right patients, and it is deeply concerning that individuals are flouting these rules and putting others at risk.
'Healthcare regulatory bodies such as the MHRA have the powers to investigate and act against any individual who is illegally supplying counterfeit products, and is taking action to do so.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
44 minutes ago
- BBC News
Tackling racism a priority, says Norfolk and Suffolk NHS Trust
Tackling "pockets of racism" in an NHS mental health trust remained a "number one priority", its chair has Billingham, the chair of Norfolk and Suffolk NHS Foundation Trust (NSFT) based in Norwich, pledged to make changes following findings from a recent staff survey found evidence that disciplinary processes for staff from a black, Asian and minority ethnic background were "more draconian".The study based on the experiences of 100 members of staff was commissioned by NSFT, and also included allegations of nepotism and inequality. Ms Billingham said: "There is undoubtedly pockets of racism within our trust."We've brought in experts from across the country to help us diagnose, where it's happening, why it's happening and we've got this movement now, across our staff, to say we've got to stop talking about being an anti-racist organisation, we have to act."Some of the racism came from patients and directed towards staff, and some staff expressed there was no clear process for dealing with racist Billingham confirmed making improvements was a top priority for the trust and that changes were not about "woke politics" but about getting the best from staff for patients."We've got to create that environment where staff are not subjected to racism, whether it's shouted or whispered, whether direct or indirect, we've got to eradicate it and stamp it out," she said. The workforce race equality report also found staff felt there were significant discrepancies in recruitment, career progression, the disciplinary process and equal included allegations of "widespread and problematic nepotism" and a fear of speaking up or making the report, NSFT's leadership was accused of not understanding race, and senior leaders were accused of not Ms Billingham also commented on a recent Care Quality Commission inspection which took place at the was removed from "special measures" status in February after more than seven years, following improvements to the findings of inspectors' visit a few days ago are yet to be made public but the chair of the NSFT said: "It's the start of our improvement journey."I'm hoping that we don't slip back, sometimes we take two steps forward and one step back."I am really optimistic that we will get better and are getting better." Follow Norfolk news on BBC Sounds, Facebook, Instagram and X.
Daily Mirror
an hour ago
- Daily Mirror
Tesco shoppers warned after supermarket puts new label on popular product
The NHS has issued a stark warning to Tesco shoppers who buy the supermarket's own-brand toilet roll, urging them to 'keep an eye out' and 'contact your GP practice if something doesn't feel right' The NHS is calling on Tesco customers to 'keep an eye out' and to 'contact your GP practice if something doesn't feel right', issuing a stark health warning as Tesco's exclusive Luxury Soft loo rolls now sport the NHS logo on their wrapping. In a bid to ramp up bowel cancer awareness, the partnership between NHS and Britain's leading grocer aims to tap into the regular shopping habits of consumers. Echoing across social media platform X, the NHS broadcasted: "Keep an eye out for our logo on @Tesco toilet roll-78.9 million rolls sold and counting!" The move acts as a timely nudge for shoppers to stay vigilant for early signs of cancer during their bathroom routine. READ MORE: 'I'm a fashion editor and found an unlikely retailer selling glitzy festival-ready outfits' The NHS is highlighting: "It's a reminder for people to look out for possible signs of cancer when going to the loo. Know what's normal for you and contact your GP practice if something doesn't feel right." On each pack, just below the NHS logo, is a critical message which reads: "Finding cancer earlier makes it more treatable and can save lives." On this unique packaging, customers will find a checklist of cancer indicators that might be detected in the loo, including changes in bowel movements or blood traces, reports the Express. For an exhaustive list of cancer symptoms, individuals are encouraged to navigate to Signs of bowel cancer include: changes in your poo, such as having softer poo, diarrhoea or constipation that is not usual for you needing to poo more or less often than usual for you blood in your poo, which may look red or black bleeding from your bottom often feeling like you need to poo, even if you've just been to the toilet tummy pain a lump in your tummy bloating losing weight without trying feeling very tired or short of breath – these are signs of anaemia, which can be caused by bowel cancer Should anyone experience symptoms of bowel cancer for more than three weeks, it's imperative to consult a doctor. The NHS offers comfort, stating: "Try not to be embarrassed. The doctor or nurse will be used to talking about these symptoms." If you observe that your stools are black or dark red, or if you're suffering from bloody diarrhoea, it's essential to arrange an urgent GP appointment or seek help from NHS 111. Assistance can be accessed by dialling 111 or using the online service at Cancer manifests in over 200 different varieties and can impact any part of the body, including organs, blood, bone marrow, and the immune system. In some cases, cancer may spread from its original location to other areas of the body, a process referred to as secondary cancer or metastasis. The specific type of cancer dictates the treatment approach. Standard treatments for cancer include surgical removal of the tumour, chemotherapy with drugs designed to eradicate cancer cells, and radiotherapy which employs radiation to target and eliminate cancer cells. Additional treatment methods might encompass immunotherapy, enhancing the immune system's ability to combat cancer, and hormone therapy, aimed at decelerating or stopping the proliferation of cancerous cells. The NHS reassures patients: "You'll be looked after by a team of specialists who will work with you to create a treatment plan that is best for you."
The Independent
an hour ago
- The Independent
More testing needed for genetic cancer risk as too many women ‘missed', experts say
A new study has revealed that families of some cancer patients are being denied the opportunity to learn about their potential cancer risk due to inconsistencies in genetic testing. Academics have warned that the absence of adequate testing for Lynch syndrome is leaving some cancer patients unaware of their risk of developing other cancers. Lynch syndrome, a rare hereditary condition, elevates the risk of cancers of the bowel, womb, and ovaries. It arises from a gene mutation affecting DNA error correction during replication, potentially leading to uncontrolled cell growth. NHS guidelines stipulate that patients with bowel or womb cancer should undergo tumour assessments for Lynch syndrome markers. The identification of these markers should prompt a referral for genetic testing, confirming the diagnosis and enabling access to support and guidance regarding cancer risks for both the patients and their families. A new study by academics at the University of Edinburgh found not all womb cancer patients are being sent for genetic testing. Researchers examined data on 2,500 womb cancer patients across the UK and Ireland between 2022 and 2023. They found that 91 per cent of tumours were tested for markers of Lynch syndrome, but the test results were not routinely communicated to the wider clinical team. This means that follow-up genetic counselling and blood tests were not always arranged. Of the 181 participants eligible for genetic counselling, just under two-thirds (64 per cent) were referred for appointments, according to the study, which has been published in the journal BMJ Oncology. Researchers said those who were referred faced long waits, resulting in high dropout rates, meaning only 48 per cent of those eligible went on to get the test. Experts from the university said gaps in testing mean some womb cancer patients with Lynch syndrome go undetected. Family members are also left vulnerable to cancer risk, unaware they may have the condition. Dr Neil Ryan, from the University of Edinburgh, who leads the UK audit and research collaborative in obstetrics and gynaecology, said: 'Despite clear guidance and excellent rates of tumour testing, too many women with Lynch syndrome are still being missed because they're not referred for definitive blood testing in a timely way. 'This not only denies them the chance to reduce their future cancer risk but also prevents their relatives from being tested and protected. 'Tumour testing is only cost-effective if it leads to diagnosis — we urgently need to make mainstream testing truly mainstream.'
